​

GH Research (GHRS) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

GHRS Stock Forecast

GH Research (GHRS) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $36.50, with a high of $40.00 and a low of $32.00. This represents a 137.63% increase from the last price of $15.36.

$5 $12 $19 $26 $33 $40 High: $40 Avg: $36.5 Low: $32 Last Closed Price: $15.36

GHRS Stock Rating

GH Research stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

GHRS Price Target Upside V Benchmarks

TypeNameUpside
StockGH Research137.63%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%
IdeaPsychedelic Stocks List121.66%

Price Target Trends

1M3M12M
# Anlaysts279
Avg Price Target$33.00$34.57$32.89
Last Closing Price$15.36$15.36$15.36
Upside/Downside114.84%125.07%114.13%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2636---9
Feb, 2636---9
Jan, 2636---9
Dec, 2536---9
Nov, 2545---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 10, 2026Eddie HickmanGuggenheim$34.00$15.81115.05%121.35%
Mar 06, 2026Ami FadiaNeedham$32.00$15.34108.60%108.33%
Jan 23, 2026RBC Capital$40.00$16.73139.09%160.42%
Jan 06, 2026Needham$29.00$15.4687.58%88.80%
Jan 06, 2026Canaccord Genuity$39.00$15.46152.26%153.91%
Jan 06, 2026Wolfe Research$39.00$15.46152.26%153.91%
Jan 05, 2026Eddie HickmanGuggenheim$29.00$15.8083.54%88.80%
Nov 10, 2025Patrick TrucchioH.C. Wainwright$35.00$13.55158.30%127.86%
Oct 13, 2025Needham$19.00$12.5950.91%23.70%
Nov 18, 2024Sumant KilkamiCanaccord Genuity$28.00$9.26202.38%82.29%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 10, 2026GuggenheimBuyBuyhold
Mar 06, 2026NeedhamBuyBuyhold
Jan 23, 2026RBC CapitalOutperformOutperformhold
Jan 06, 2026NeedhamBuyBuyhold
Jan 06, 2026CitigroupMarket OutperformMarket Outperformhold
Jan 05, 2026Cowen & Co.BuyBuyhold
Jan 05, 2026GuggenheimBuyBuyhold
Nov 10, 2025H.C. WainwrightBuyBuyhold
Oct 13, 2025NeedhamBuyinitialise
Mar 07, 2025RBC CapitalOutperforminitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.68-----
Avg Forecast$-0.67$-0.80$-1.11$-1.19$-1.08$-0.65
High Forecast$-0.64$-0.80$-0.85$-0.91$-0.93$-0.65
Low Forecast$-0.69$-0.81$-1.56$-1.69$-1.31$-0.65
Surprise %1.49%-----

Revenue Forecast

$35M $39M $43M $47M $51M $55M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast----$50.65M$35.03M
High Forecast----$50.65M$35.03M
Low Forecast----$50.65M$35.03M
Surprise %------

Net Income Forecast

$-90M $-78M $-66M $-54M $-42M $-30M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-35.59M-----
Avg Forecast$-35.59M$-41.79M$-65.80M$-74.10M$-58.33M$-33.99M
High Forecast$-33.52M$-41.53M$-44.11M$-47.33M$-48.31M$-33.99M
Low Forecast$-36.09M$-42.05M$-81.03M$-87.97M$-68.35M$-33.99M
Surprise %------

GHRS Forecast FAQ

Is GH Research stock a buy?

GH Research stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that GH Research is a favorable investment for most analysts.

What is GH Research's price target?

GH Research's price target, set by 8 Wall Street analysts, averages $36.5 over the next 12 months. The price target range spans from $32 at the low end to $40 at the high end, suggesting a potential 137.63% change from the previous closing price of $15.36.

How does GH Research stock forecast compare to its benchmarks?

GH Research's stock forecast shows a 137.63% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%), leading the psychedelic stocks list (121.66%) investment idea.

What is the breakdown of analyst ratings for GH Research over the past three months?

  • March 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is GH Research’s EPS forecast?

GH Research's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.8, marking a 17.65% increase from the reported $-0.68 in 2023. Estimates for the following years are $-1.11 in 2025, $-1.19 in 2026, $-1.08 in 2027, and $-0.65 in 2028.

What is GH Research’s revenue forecast?

GH Research's average annual revenue forecast for its fiscal year ending in December 2024 is $0, reflecting a 0% decrease from the reported $0 in 2023. The forecast for 2025 is $0, followed by $0 for 2026, $50.65M for 2027, and $35.03M for 2028.

What is GH Research’s net income forecast?

GH Research's net income forecast for the fiscal year ending in December 2024 stands at $-41.791M, representing an 17.43% increase from the reported $-35.587M in 2023. Projections indicate $-65.8M in 2025, $-74.1M in 2026, $-58.326M in 2027, and $-33.988M in 2028.